Evidence map›Paper›PMID 36371414›Full record

ArticleScientific reports2022

Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach.

Ashita Singh, Monikaben Padariya, Jakub Faktor, Sachin Kote, Sara Mikac, Alicja Dziadosz, Tak W Lam, Jack Brydon, Martin A Wear, Kathryn L Ball and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Ashita SinghInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK.
Monikaben PadariyaInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland.
Jakub FaktorInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland.
Sachin KoteInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland.
Sara MikacInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland.
Alicja DziadoszInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland.
Tak W LamInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK.
Jack BrydonInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK.
Martin A WearSchool of Biological Sciences, Institute of Structural and Molecular Biology, University of Edinburgh, Edinburgh, EH9 3JR, UK.
Kathryn L BallInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK.
Ted HuppInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, Scotland, UK.
Alicja SznarkowskaInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland.
Borek VojtesekRECAMO, Masaryk Memorial Cancer Institute, Zlutykopec 7, 65653, Brno, Czech Republic. vojtesek@mou.cz.
Umesh KalathiyaInternational Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822, Gdansk, Poland. umesh.kalathiya@ug.edu.pl.
University of Gdańsk · PLEdinburgh Cancer Research · GBMasaryk Memorial Cancer Institute · CZUniversity of Edinburgh · GB

Funding

Czech Science Foundation GACR 22-02940SEuropean Regional Development Fund CZ.02.1.01/0.0/0.0/16_019/0000868Narodowe Centrum Nauki 2020/36/C/NZ2/00108
6 · The paper itself

Abstract

The interferon signalling system elicits a robust cytokine response against a wide range of environmental pathogenic and internal pathological signals, leading to induction of a subset of interferon-induced proteins. We applied DSS (disuccinimidyl suberate) mediated cross-linking mass spectrometry (CLMS) to capture novel protein-protein interactions within the realm of interferon induced proteins. In addition to the expected interferon-induced proteins, we identified novel inter- and intra-molecular cross-linked adducts for the canonical interferon induced proteins, such as MX1, USP18, OAS3, and STAT1. We focused on orthogonal validation of a cohort of novel interferon-induced protein networks formed by the HLA-A protein (H2BFS-HLA-A-HMGA1) using co-immunoprecipitation assay, and further investigated them by molecular dynamics simulation. Conformational dynamics of the simulated protein complexes revealed several interaction sites that mirrored the interactions identified in the CLMS findings. Together, we showcase a proof-of-principle CLMS study to identify novel interferon-induced signaling complexes and anticipate broader use of CLMS to identify novel protein interaction dynamics within the tumour microenvironment.

Indexed as

InterferonsProteinsCross-Linking ReagentsHLA-A AntigensHLA AntigensHumansMass SpectrometryUbiquitin ThiolesteraseCross-Linking ReagentsHLA-A AntigensHLA AntigensInterferonsProteinsUbiquitin ThiolesteraseUSP18 protein, human

Identifiers

PMID36371414
PMCPMC9653400
OpenAlexW4309046822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.